Bridgewater – November 04, 2026 -- Insmed Incorporated (Nasdaq: INSM) will put management in front of investors at two healthcare conferences within a span of 15 days, starting November 16 in London.
Insmed management to present at Jefferies in London on November 16
The company will appear at the Jefferies Global Healthcare Conference in London on Monday, November 16, 2026, at 9:00 a.m. ET.
Evercore session in Coral Gables is set for December 1
Management will then present at the Evercore 9th Annual Healthcare Conference in Coral Gables, Florida, on Tuesday, December 1, 2026, at 9:10 a.m. ET.
Both presentations will be webcast live and archived for 30 days
Both events will be webcast live through the investor relations section of Insmed's website. Each webcast will remain archived for 30 days after the live event ends.
Insmed's approved lung therapies and three therapeutic areas frame the investor pitch
Insmed, headquartered in Bridgewater, New Jersey, markets two approved therapies for chronic, debilitating lung diseases. Its commercial portfolio and clinical pipeline are organized around three areas: Respiratory, Immunology & Inflammation, and Neuro & Other Rare. The research engine is working on gene therapy, AI-driven protein engineering, RNA end-joining and synthetic rescue to generate future pipeline candidates.